These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32868026)

  • 1. Diagnostic value of modified systemic inflammation score for prediction of malignancy in patients with indeterminate thyroid nodules.
    Ataş H; Korukluoğlu B; Özdemir BA; Yakşi N; Saylam B; Tez M
    Am J Surg; 2021 Jan; 221(1):117-121. PubMed ID: 32868026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can preoperative modified systemic inflammation score (mSIS) be used to predict malignancy in persistent nondiagnostic thyroid nodules?
    Ataş H; Korukluoğlu B; Çomçali B; Yakşi N; Saylam B; Tez M
    Turk J Med Sci; 2021 Apr; 51(2):700-705. PubMed ID: 33550761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified Systemic Inflammation Score is Useful for Risk Stratification After Radical Resection of Squamous Cell Carcinoma of the Esophagus.
    Kanda M; Koike M; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Yamada S; Omae K; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2019 Dec; 26(13):4773-4781. PubMed ID: 31605344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate Prediction of Prognosis After Radical Resection of Gastric Cancer by the Modified Systemic Inflammation Score; a Multicenter Dataset Analysis.
    Inagaki K; Kanda M; Nakanishi K; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
    World J Surg; 2021 Aug; 45(8):2513-2520. PubMed ID: 33934199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of LMR, NLR and PLR as predictors of malignancy in indeterminate thyroid nodules.
    Offi C; Romano RM; Cangiano A; Filograna Pignatelli M; Candela G; Docimo G
    Acta Otorhinolaryngol Ital; 2021 Dec; 41(6):530-536. PubMed ID: 34928264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer.
    Lin JX; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Li P
    Gastric Cancer; 2019 Mar; 22(2):403-412. PubMed ID: 29982861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic value of modified systemic ınflammation score in predicting post-operative outcomes of cutaneous melanoma patients who underwent ısolated limb perfusion.
    Morkavuk ŞB; Çulcu S; Esen E; Ünal AE
    World J Surg Oncol; 2021 Nov; 19(1):327. PubMed ID: 34781987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules.
    Batawil N; Alkordy T
    Eur J Surg Oncol; 2014 Feb; 40(2):182-6. PubMed ID: 24373298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The large majority of 1520 patients with indeterminate thyroid nodule at cytology have a favorable outcome, and a clinical risk score has a high negative predictive value for a more cumbersome cancer disease.
    Rago T; Scutari M; Latrofa F; Loiacono V; Piaggi P; Marchetti I; Romani R; Basolo F; Miccoli P; Tonacchera M; Vitti P
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3700-7. PubMed ID: 24708101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
    Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
    BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasonography scoring systems can rule out malignancy in cytologically indeterminate thyroid nodules.
    Grani G; Lamartina L; Ascoli V; Bosco D; Nardi F; D'Ambrosio F; Rubini A; Giacomelli L; Biffoni M; Filetti S; Durante C; Cantisani V
    Endocrine; 2017 Aug; 57(2):256-261. PubMed ID: 27804016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A risk model to determine surgical treatment in patients with thyroid nodules with indeterminate cytology.
    Macias CA; Arumugam D; Arlow RL; Eng OS; Lu SE; Javidian P; Davidov T; Trooskin SZ
    Ann Surg Oncol; 2015 May; 22(5):1527-32. PubMed ID: 25388058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bethesda Category III, IV, and V Thyroid Nodules: Can Nodule Size Help Predict Malignancy?
    Kiernan CM; Solórzano CC
    J Am Coll Surg; 2017 Jul; 225(1):77-82. PubMed ID: 28223197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Inflammatory Biomarkers (NLR, LMR, PLR) in the Prognostication of Malignancy in Indeterminate Thyroid Nodules.
    Gambardella C; Mongardini FM; Paolicelli M; Bentivoglio D; Cozzolino G; Ruggiero R; Pizza A; Tolone S; Del Genio G; Parisi S; Brusciano L; Cerbara L; Docimo L; Lucido FS
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm.
    Sorrenti S; Trimboli P; Catania A; Ulisse S; De Antoni E; D'Armiento M
    Thyroid; 2009 Apr; 19(4):355-60. PubMed ID: 19355826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Risk Stratification of Indeterminate Thyroid Nodules: A Cytological Approach.
    Valderrabano P; Khazai L; Thompson ZJ; Leon ME; Otto KJ; Hallanger-Johnson JE; Wadsworth JT; Wenig BM; Chung CH; Centeno BA; McIver B
    Thyroid; 2017 Oct; 27(10):1277-1284. PubMed ID: 28806881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of surgeon-performed ultrasound in predicting malignancy in patients with indeterminate thyroid nodules.
    Méndez W; Rodgers SE; Lew JI; Montano R; Solórzano CC
    Ann Surg Oncol; 2008 Sep; 15(9):2487-92. PubMed ID: 18622644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules.
    Sahin M; Gursoy A; Tutuncu NB; Guvener DN
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):514-8. PubMed ID: 16984245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to approach thyroid nodules with indeterminate cytology.
    Yoon JH; Kwak JY; Kim EK; Moon HJ; Kim MJ; Kim JY; Koo HR; Kim MH
    Ann Surg Oncol; 2010 Aug; 17(8):2147-55. PubMed ID: 20217250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma.
    An JH; Song KH; Kim SK; Park KS; Yoo YB; Yang JH; Hwang TS; Kim DL
    Clin Endocrinol (Oxf); 2015 May; 82(5):760-6. PubMed ID: 25109485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.